| MeSH term | MeSH ID | Detail |
|---|---|---|
| Vision Disorders | D014786 | 10 associated lipids |
| Multiple Myeloma | D009101 | 13 associated lipids |
| Osteoporosis | D010024 | 12 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Otosclerosis | D010040 | 2 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Hypersensitivity, Delayed | D006968 | 43 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Calcinosis | D002114 | 5 associated lipids |
7-octadecynoic acid
7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
All references with 7-octadecynoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kwon A et al. | Serum Osteoprotegerin Is Associated With Calcified Carotid Plaque: A Strobe-Compliant Observational Study. | 2016 | Medicine (Baltimore) | pmid:27082605 |
| Hsu BG et al. | Serum Sclerostin as an Independent Marker of Peripheral Arterial Stiffness in Renal Transplantation Recipients: A Cross-Sectional Study. | 2016 | Medicine (Baltimore) | pmid:27082570 |
| Zhang L et al. | Effects of IL-10 and glucose on expression of OPG and RANKL in human periodontal ligament fibroblasts. | 2016 | Braz. J. Med. Biol. Res. | pmid:27074164 |
| Song DH et al. | Relationships of OPG Genetic Polymorphisms with Susceptibility to Cardiovascular Disease: A Meta-Analysis. | 2016 | Med. Sci. Monit. | pmid:27068490 |
| Kose O et al. | Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. | 2016 | Mar Drugs | pmid:27043583 |
| Shah AP et al. | Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. | 2016 | PLoS ONE | pmid:27019421 |
| Dela Cruz A et al. | Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. | 2016 | Am. J. Physiol. Endocrinol. Metab. | pmid:27006198 |
| Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
| Tsuruda T et al. | Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. | 2016 | Hypertension | pmid:27001297 |
| Li N et al. | Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. | 2016 | Pharmazie | pmid:29441931 |
| Gautam J et al. | An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. | 2016 | J. Pharm. Pharmacol. | pmid:27265669 |
| Maser RE et al. | Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. | 2016 | J. Diabetes Complicat. | pmid:26775555 |
| Gottesman GS et al. | Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. | 2016 | Am. J. Med. Genet. A | pmid:26762549 |
| Totoson P et al. | Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. | 2016 | PLoS ONE | pmid:26761790 |
| Kuroda Y et al. | Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. | 2016 | PLoS ONE | pmid:26751951 |
| Bougioukli S et al. | Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect. | 2016 | Bone | pmid:26723577 |
| Kobayashi Y et al. | Regulation of bone metabolism by Wnt signals. | 2016 | J. Biochem. | pmid:26711238 |
| Yuan SY et al. | Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. | 2016 | Chin J Nat Med | pmid:27114313 |
| Chen Z et al. | Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway. | 2016 | Int. J. Mol. Med. | pmid:26677102 |
| Johnson DC et al. | Genetic factors influencing the risk of multiple myeloma bone disease. | 2016 | Leukemia | pmid:26669972 |
| Davaine JM et al. | Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. | 2016 | Eur J Vasc Endovasc Surg | pmid:26652270 |
| Li J et al. | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. | 2016 | Mol Med Rep | pmid:26647856 |
| Cervellati C et al. | Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. | 2016 | Oxid Med Cell Longev | pmid:26635910 |
| Iezaki T et al. | The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. | 2016 | J. Bone Miner. Res. | pmid:26391411 |
| Meijome TE et al. | C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis. | 2016 | J. Cell. Biochem. | pmid:26375403 |
| Zhao N et al. | Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. | 2016 | J. Bone Miner. Res. | pmid:26274352 |
| Liu YD et al. | Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. | 2016 | Osteoarthr. Cartil. | pmid:26256766 |
| Pietschmann P et al. | Immunology of Osteoporosis: A Mini-Review. | 2016 | Gerontology | pmid:26088283 |
| Wang S et al. | Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. | 2016 | J Ethnopharmacol | pmid:27109342 |
| Kim CS et al. | Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. | 2016 | PLoS ONE | pmid:27855207 |
| Li XJ et al. | Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. | 2016 | Int. J. Mol. Med. | pmid:27840967 |
| Zhou J and Zhao Y | Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. | 2016 | Med. Sci. Monit. | pmid:27828936 |
| Ostrowska Z et al. | TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. | 2016 | Endokrynol Pol | pmid:27828689 |
| Kan C et al. | Cancer Cell Colonisation in the Bone Microenvironment. | 2016 | Int J Mol Sci | pmid:27782035 |
| Huang HM et al. | Effects of Roughly Focused Extracorporeal Shock Waves Therapy on the Expressions of Bone Morphogenetic Protein-2 and Osteoprotegerin in Osteoporotic Fracture in Rats. | 2016 | Chin. Med. J. | pmid:27779163 |
| Kamata R et al. | EPA Prevents the Development of Abdominal Aortic Aneurysms through Gpr-120/Ffar-4. | 2016 | PLoS ONE | pmid:27764222 |
| Liu HJ et al. | Substance P Promotes the Proliferation, but Inhibits Differentiation and Mineralization of Osteoblasts from Rats with Spinal Cord Injury via RANKL/OPG System. | 2016 | PLoS ONE | pmid:27764190 |
| Menzel J et al. | Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator. | 2016 | J. Endocrinol. Invest. | pmid:27614458 |
| O'Sullivan S et al. | Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. | 2016 | PLoS ONE | pmid:27737004 |
| Li M et al. | Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. | 2016 | J. Biol. Chem. | pmid:27697839 |
| Shirakawa J and Kulkarni RN | Novel factors modulating human β-cell proliferation. | 2016 | Diabetes Obes Metab | pmid:27615134 |
| Xing R et al. | Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. | 2016 | Int. J. Mol. Med. | pmid:27599586 |
| Yongdi L et al. | [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. | 2016 | Hua Xi Kou Qiang Yi Xue Za Zhi | pmid:27526445 |
| Qian H et al. | FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. | 2016 | Mol Med Rep | pmid:27510616 |
| Røysland R et al. | Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. | 2016 | PLoS ONE | pmid:27463973 |
| Bernardi S et al. | Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. | 2016 | Biomed Res Int | pmid:27200369 |
| Wei CC et al. | Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. | 2016 | Mediators Inflamm. | pmid:27199510 |
| Usategui-MartÃn R et al. | VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. | 2016 | Genet Test Mol Biomarkers | pmid:27172236 |
| Sun J et al. | Daidzein increases OPG/RANKL ratio and suppresses IL-6 in MG-63 osteoblast cells. | 2016 | Int. Immunopharmacol. | pmid:27576059 |
| Li B et al. | Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. | 2016 | Int J Mol Sci | pmid:27110777 |